Moving Radioimmunotherapy Forward for Follicular Lymphoma

被引：3

作者：

Witzig, Thomas E. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN 55905 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 03期

关键词：

NON-HODGKINS-LYMPHOMA; REFRACTORY LOW-GRADE; LOW-TUMOR-BURDEN; PHASE-II TRIAL; I-131; TOSITUMOMAB; ADVANCED-STAGE; THERAPY; POLICY;

D O I：

10.1200/JCO.2012.46.2663

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：294 / 296

页数：3

共 16 条

[1] Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial [J].

Ardeshna, KM ;

Smith, P ;

Norton, A ;

Hancock, BW ;

Hoskin, PJ ;

MacLennan, KA ;

Marcus, RE ;

Jelliffe, A ;

Hudson, GV ;

Linch, DC .

LANCET, 2003, 362 (9383) :516-522

[2] Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: A randomized study from the Groupe D'Etude des Lymphomes Folliculaires [J].

Brice, P ;

Bastion, Y ;

Lepage, E ;

Brousse, N ;

Haioun, C ;

Moreau, P ;

Straetmans, N ;

Tilly, H ;

Tabah, I ;

SolalCeligny, P .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :1110-1117

[3] Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden:: clinical and molecular evaluation [J].

Colombat, P ;

Salles, G ;

Brousse, N ;

Eftekhari, P ;

Soubeyran, P ;

Delwail, V ;

Deconinck, E ;

Haïoun, C ;

Foussard, C ;

Sebban, C ;

Stamatoullas, A ;

Milpied, N ;

Boué, F ;

Taillan, B ;

Lederlin, P ;

Najman, A ;

Thièblemont, C ;

Montestruc, F ;

Mathieu-Boué, A ;

Benzohra, A ;

Solal-Céligny, P .

BLOOD, 2001, 97 (01) :101-106

[4]

Davis TA, 2001, BLOOD, V98, p843A

[5] Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project [J].

Federico, Massimo ;

Bellei, Monica ;

Marcheselli, Luigi ;

Luminari, Stefano ;

Lopez-Guillermo, Armando ;

Vitolo, Umberto ;

Pro, Barbara ;

Pileri, Stefano ;

Pulsoni, Alessandro ;

Soubeyran, Pierre ;

Cortelazzo, Sergio ;

Martinelli, Giovanni ;

Martelli, Maurizio ;

Rigacci, Luigi ;

Arcaini, Luca ;

Di Raimondo, Francesco ;

Merli, Francesco ;

Sabattini, Elena ;

McLaughlin, Peter ;

Solal-Celigny, Philippe .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4555-4562

[6] Tositumomab and Iodine I-131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma: Median 10 Year Follow-up Results [J].

Kaminski, Mark S. ;

Tuck, Melissa ;

Estes, Judith ;

Kolstad, Arne ;

Ross, Charles Warren ;

Regan, Denise ;

Horner, Thierry ;

Williams, Vanessa C. ;

Vleisides, Tina ;

Wahl, Richard L. .

BLOOD, 2009, 114 (22) :1447-1447

[7] 131I-tositumomab therapy as initial treatment for follicular lymphoma [J].

Kaminski, MS ;

Tuck, M ;

Estes, J ;

Kolstad, A ;

Ross, CW ;

Zasadny, K ;

Regan, D ;

Kison, P ;

Fisher, S ;

Kroll, S ;

Wahl, RL .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (05) :441-449

[8] Phase III Trial of Consolidation Therapy With Yttrium-90-Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma [J].

Morschhauser, Franck ;

Radford, John ;

Van Hoof, Achiel ;

Vitolo, Umberto ;

Soubeyran, Pierre ;

Tilly, Herve ;

Huijgens, Peter C. ;

Kolstad, Arne ;

d'Amore, Francesco ;

Diaz, Marcos Gonzalez ;

Petrini, Mario ;

Sebban, Catherine ;

Zinzani, Pier Luigi ;

van Oers, Marinus H. J. ;

van Putten, Wim ;

Bischof-Delaloye, Angelika ;

Rohatiner, Ama ;

Salles, Gilles ;

Kuhlmann, Jens ;

Hagenbeek, Anton .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) :5156-5164

[9] Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: Five-year follow-up of Southwest Oncology Group protocol S9911 [J].

Press, Oliver W. ;

Unger, Joseph M. ;

Braziel, Rita M. ;

Maloney, David G. ;

Miller, Thomas P. ;

LeBlanc, Michael ;

Fisher, Richard I. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) :4143-4149

[10] Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus 131Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin Lymphoma: SWOG S0016 [J].

Press, Oliver W. ;

Unger, Joseph M. ;

Rimsza, Lisa M. ;

Friedberg, Jonathan W. ;

LeBlanc, Michael ;

Czuczman, Myron S. ;

Kaminski, Mark ;

Braziel, Rita M. ;

Spier, Catherine ;

Gopal, Ajay K. ;

Maloney, David G. ;

Cheson, Bruce D. ;

Dakhil, Shaker R. ;

Miller, Thomas P. ;

Fisher, Richard I. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :314-320

← 1 2 →